pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 371 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    GADLEN Multiple-CD20
    Unspecified Cancer$STTK Shattuck Labs, Inc.
  • Preclinical
    GB-910
    Rheumatoid Arthritis Gbiologics Inc
  • Phase 3
    GC-5107D
    Primary Humoral Immune Deficiencies GC Biopharma Corp
  • Phase 2
← prev
page 5 of 13
next →
Pain89
Neurology1
GCC-4001
Idiopathic Inflammatory Myopathy (IIM)
$ARTV Artiva Biotherapeutics, Inc.
  • Preclinical
    GRI-0803
    Systemic Lupus Erythematosus$GRI GRI Bio, Inc.
  • Phase 1
    GS-6791
    Rheumatoid Arthritis$GILD GILEAD SCIENCES, INC.
  • Phase 2
    Gene Therapy to Activate Artemis for Severe Combined Immune Deficiency
    Severe Combined Immune Deficiency (SCID) University of California San Francisco
  • Phase 2
    Gene Therapy to Activate IL-2 Gamma Receptor for SCID-X1
    X-Linked SCID Boston Children's Hospital
  • Phase 1
    HNC-1058
    Idiopathic Pulmonary Fibrosis Guangzhou Henovcom Bioscience Co Ltd
  • Preclinical
    HT-KIT
    Anaphylaxis$HOTH Hoth Therapeutics, Inc.
  • Marketed
    Haegarda
    Haegarda (C1 esterase inhibitor (human))
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… CSL Behring LLC
  • Phase 1
    IA-14069
    Rheumatoid Arthritis iLab Co Ltd
  • Preclinical
    ICT-6401
    Autoimmune Disorders Innovative Cellular Therapeutics Co Ltd
  • Phase 2
    IM-101
    Myasthenia Gravis ImmunAbs Inc
  • Preclinical
    INB-619
    Systemic Lupus Erythematosus$INAB IN8BIO, INC.
  • Phase 1
    INT-301
    Peanut Allergy Intrommune Therapeutics Inc
  • Preclinical
    Immunology
    Unspecified Immunological Disorders Dawn Sea Therapeutics
  • Phase 2
    KBLP-001
    Plaque Psoriasis (Psoriasis Vulgaris) KoBioLabs Inc
  • Phase 1
    KINE-101A
    Rheumatoid Arthritis Kine Sciences
  • Preclinical
    KPV
    Inflammation PharmaTher Holdings Ltd
  • Preclinical
    KQ-2512
    Systemic Lupus Erythematosus Novatim Immune Therapeutics (Zhejiang) Co Ltd
  • Preclinical
    LBL-051
    Lupus Nephritis Nanjing Leads Biolabs Co Ltd
  • Preclinical
    LCTG-001
    Common Variable Immunodeficiency (CVID) Lactiga Inc
  • Phase 2
    LIS-1
    Kidney Transplant Rejection Xenothera SAS
  • Phase 1
    LPXTI-641
    Psoriatic Arthritis Lapix Therapeutics Inc
  • Preclinical
    MPB-2354
    Rheumatoid Arthritis MegaPro Biomedical Co Ltd
  • Phase 1
    MRT-6160
    Axial Spondyloarthritis$NVS NOVARTIS AG
  • Phase 1
    MRT-8102
    Inflammation$GLUE Monte Rosa Therapeutics, Inc.
  • Phase 2
    MaaT-013
    Graft Versus Host Disease (GVHD) MaaT Pharma SA
  • Marketed
    Mestinon
    Mestinon (pyridostigmine bromide)
    Myasthenia Gravis Bausch Health US LLC